Juvaris BioTherapeutics Raises $25 Million
Juvaris BioTherapeutics Inc., a Pleasanton, Calif.-based developer of vaccines for cancer and infectious diseases, has raised $25 million in the first close of a Series B round. SV Life Sciences led the round, and was joined by return backer Kleiner Perkins Caufield & Byers.
17 September 2009•3 mins read
